Encompass Health Corp (EHC) Form 8-K — Oct 28, 2026
Encompass Health (NYSE: EHC) reported Q3 2026 results with net operating revenue of $1,609.5 million, up 8.9% year over year, and Adjusted EBITDA of $346.6 million, up 15.5%. Adjusted EPS rose 23.6% to $1.52 from $1.23. The company raised its full-year 2026 guidance across the board: revenue to $6,450-$6,500 million, Adjusted EBITDA to $1,395-$1,415 million, and adjusted EPS to $6.23-$6.37. It also opened four hospitals (189 beds) year to date and added 85 beds to existing facilities.
Key figures
- Eps
- 1.52
- Guidance
- Full-year 2026 raised to net operating revenue $6,450-$6,500M (from $6,410-$6,490M), Adjusted EBITDA $1,395-$1,415M (from $1,365-$1,395M), adjusted EPS $6.23-$6.37 (from $6.02-$6.25)
- Net Income
- 149.9
- Total Debt
- 2599.1
- Revenue Yoy
- 8.9%
- Cash Position
- 76.2
- Buyback q3
- $57.9 million (494,657 shares)
- Net leverage
- 1.8x
- Discharges q3
- 69605
- Adjusted ebitda q3
- 346.6
- Hospitals operated
- 177
- Quarterly dividend
- $0.21 per share
- Adjusted eps growth
- 23.6%
- Buyback authorization
- $1.0 billion
- Adjusted ebitda growth
- 15.5%
- Adjusted free cash flow q3
- 263.4
- Same store discharge growth
- 3.0%
- Net patient revenue per discharge
- 22543
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.